首页|微聚焦超声联合可注射型胶原蛋白在面部年轻化治疗中的应用

微聚焦超声联合可注射型胶原蛋白在面部年轻化治疗中的应用

扫码查看
目的:评估微聚焦超声与可注射型胶原蛋白联合应用对面部年轻化改善的效果及安全性.方法:选取2021年9月-2023年6月在北京友谊医院皮肤科门诊就诊的96例就医者,随机分为对照组(48例)和联合组(48例),对照组仅使用微聚焦超声治疗,联合组首先使用微聚焦超声治疗,在术后3个月时对就医者泪沟处进行胶原蛋白注射.以微聚焦超声术后为治疗监测时间起点,收集两组就医者微聚焦超声术后3个月、4个月及胶原蛋白注射术后1个月的照片,最终主要观察指标为微聚焦超声术后4个月与联合应用胶原蛋白术后1个月两组就医者的临床效果及满意度.结果:联合组总有效率为95.74%,总满意度为93.62%,显著高于对照组71.74%(P<0.05),76.09%(P<0.05).结论:微聚焦超声与可注射型胶原蛋白联合应用对面部年轻化改善效果显著,疼痛度低,并发症少,就医者的满意度较高.
Application of Micro-Focused Ultrasound Combined with Injectable Collagen in Facial Rejuvenation Treatment
Objective To assess the efficacy and safety of the combined application of micro-focused ultrasound(MFU)and injectable collagen for facial rejuvenation.Methods Ninety-six patients who visited the dermatology outpatient department at Beijing Friendship Hospital between September 2021 and June 2023 were randomly assigned to two groups:the control group(48 patients)and the combination treatment group(48 patients).The control group received only MFU treatment,while the combination group underwent MFU treatment followed by a collagen injection in the tear trough area three months post-procedure.Photographs were taken at three and four months post-MFU treatment and one month post-collagen injection.The primary outcome measures were clinical efficacy and patient satisfaction at four months post-MFU and one month post-collagen injection.Results The overall effective rate of the combination treatment group was 95.74%,and the overall satisfaction rate was 93.62%,significantly higher than those of the control group,which were 71.74%(P<0.05)and 76.09%(P<0.05),respectively.Conclusion The combination of micro-focused ultrasound and injectable collagen significantly improves facial rejuvenation outcomes,with minimal pain,fewer complications,and higher patient satisfaction.

micro-focused ultrasoundcollagenfacial rejuvenationsafeinjection

包彤、郑佳兴、杨高云、李邻峰

展开 >

首都医科大学附属北京友谊医院皮肤科 北京 100050

微聚焦超声 胶原蛋白 面部年轻化 安全性 注射

2024

中国美容医学
西安交通大学第四军医大学

中国美容医学

CSTPCD
影响因子:1.006
ISSN:1008-6455
年,卷(期):2024.33(12)